Friday, April 4, 2014

This Week in Sickle Cell News

Hello and Happy April! 

This weeks selection:


Patient Care

Randomized Controlled Trial of Sildenafil for Preventing Recurrent Ischemic Priapism in Sickle Cell Disease 

Mechanistic Insights and Characterization of Sickle Cell Disease Associated Cardiomyopathy
Outcomes of Adult Patients With Sickle-Cell Disease Admitted to the ICU: A Case Series
Association between Morphometric Variables and Nocturnal Desaturation in Sickle-Cell Anemia 

Self-reported Transition Readiness Among Young Adults With Sickle Cell Disease

Association of serum Interlukin-6 and Glycolysis in Sickle Cell Disease Patients

Prevalence of Pulmonary Hypertension in Sickle Cell Anaemia Patients of a Tertiary Hospital in Nigeria 




Research

Platelet Bioenergetic Screen in Sickle Cell Patients Reveals Mitochondrial Complex V inhibition which Contributes to Platelet Activation 

A Double-blind, Placebo-controlled Phase II Study of the Efficacy and Safety of 2,2 dimethylbutyrate (HQK-1001), an Oral Fetal Globin Inducer, in Sickle Cell Disease 

Use of Long Chain Polyunsaturated Fatty Acid Derivatives to Treat  Sickle Cell Disease (Patent Application)



A Study of Red Cell Parameters in Patients of Sickle Cell Trait


Hematological Profile in Patients of Sickle Cell Anemia and Sickle Cell Trait in Relation to BloodGas Analysis—Revisited


How Do We Use Molecular Red Blood Cell Antigen Typing to Supplement Pretransfusion Testing?

No comments:

Post a Comment